Literature DB >> 16380721

Amyloid double trouble.

John Hardy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16380721     DOI： 10.1038/ng0106-11

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

Review 1.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

Review 2.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

Authors:  R Deane; A Sagare; B V Zlokovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.

Authors:  Hong-Duck Kim; Kazuki Tahara; J Adam Maxwell; Robert Lalonde; Tatsuya Fukuiwa; Kohtaro Fujihashi; Kent R Van Kampen; Fan-Kun Kong; De-chu C Tang; Ken-ichiro Fukuchi
Journal:  J Gene Med       Date:  2007-02       Impact factor: 4.565

Review 4.  Mitochondria at the neuronal presynapse in health and disease.

Authors:  Michael J Devine; Josef T Kittler
Journal:  Nat Rev Neurosci       Date:  2018-01-19       Impact factor: 34.870

Review 5.  Parkinson's disease and α-synuclein expression.

Authors:  Michael J Devine; Katrina Gwinn; Andrew Singleton; John Hardy
Journal:  Mov Disord       Date:  2011-09-01       Impact factor: 10.338

Review 6.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

Review 7.  The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.

Authors:  Robert Vassar; Dora M Kovacs; Riqiang Yan; Philip C Wong
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

8.  Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.

Authors:  Andrew R Schneider; Youssef Sari
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

9.  Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications.

Authors:  Jinghong Kou; Junling Yang; Jeong-Eun Lim; Abhinandan Pattanayak; Min Song; Stephanie Planque; Sudhir Paul; Ken-Ichiro Fukuchi
Journal:  Mol Neurobiol       Date:  2014-04-15       Impact factor: 5.590

Review 10.  Protein homeostasis and aging in neurodegeneration.

Authors:  Peter M Douglas; Andrew Dillin
Journal:  J Cell Biol       Date:  2010-09-06       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.